SAN CLEMENTE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight reduction and metabolic health-solutions firm, in the present day introduced the launch of a complicated line of dietary supplements for bariatric surgical procedure and medical weight reduction sufferers, ReShape Optimize™ by ProCare Well being®. Merchandise from the brand new complement line might be obtainable for buy within the ReShape Marketplace ™, an extension of reshapecare™, the corporate’s reimbursed digital well being service prescribed by physicians for weight reduction.
“We’re enthusiastic about partnering with ProCare Well being, a frontrunner in bariatric multivitamins and dietary supplements, and stay up for working collectively in addressing affected person demand for high quality, focused supplementation that addresses particular person wants and dietary deficiencies,” commented Bart Bandy, President and Chief Government Officer at ReShape Lifesciences™. “We’re proud so as to add this product line to our ReShape Market and strengthen our centered product and repair providing for sufferers progressing alongside their well being and wellness journeys.”
Seventy-seven p.c of U.S. adults – greater than 195 million – take dietary supplements. Sure people, together with those that have had bariatric surgical procedure (weight-loss surgical procedure), profit from taking multivitamins and dietary supplements to stop dietary deficiencies. The ReShape Optimize line might be offering customers with dietary supplements within the areas of a multivitamin, multivitamin with iron, multivitamin with a probiotic, calcium, therapeutics and protein.
“We’re thrilled to accomplice with ReShape Lifesciences on the launch of their first complement line,” stated Nick Wiegand, President and Chief Government Officer at ProCare Well being. “ReShape Lifesciences has constructed a sturdy program serving to bariatric physicians take care of sufferers, and these dietary supplements will additional elevate the corporate’s success as a frontrunner within the weight-loss house.”
ABOUT RESHAPE LIFESCIENCES, INC.
ReShape Lifesciences™ is America’s premier weight reduction and metabolic health-solutions firm, providing an built-in portfolio of confirmed services and products that handle and deal with weight problems and metabolic illness. The FDA-approved Lap-Band® Program offers minimally invasive, long-term therapy of weight problems and is a substitute for extra invasive surgical stapling procedures such because the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outdoors the U.S.) minimally invasive, laparoscopically implanted medical machine that wraps across the abdomen, emulating the gastric quantity discount impact of standard weight-loss surgical procedure. It helps allow speedy weight reduction in overweight and morbidly overweight sufferers with out completely altering affected person anatomy. reshapecare™ is a digital weight-management program that helps way of life modifications for all weight-loss sufferers led by board licensed well being coaches to assist them maintain the burden off over time. The just lately launched ReShape Market™ is a web-based assortment of high quality wellness merchandise curated for all customers to assist them obtain their well being targets.
ABOUT PROCARE HEALTH ProCare Well being is a frontrunner within the bariatric complement market with a deal with post-surgery dietary wants to make sure sufferers meet their weight reduction targets. With the experience of bariatric medical doctors and dietitians, ProCare Well being shortly grew and have become the primary alternative of Bariatric Packages. Whereas we’ve continued to develop, we’ve at all times stayed true to holding our course of simple, our merchandise reasonably priced, and our sufferers blissful and wholesome!
For extra data on ProCare Well being, please go to http://www.procarenow.com.
Ahead-Trying Secure Harbor Assertion:
This press launch could comprise forward-looking statements throughout the that means of the Non-public Securities Litigation Reform Act of 1995. These forward-looking statements usually may be recognized by way of phrases similar to “count on,” “plan,” “anticipate,” “might,” “could,” “intend,” “will,” “proceed,” “future,” different phrases of comparable that means and using future dates. These forward-looking statements are based mostly on the present expectations of our administration and contain identified and unknown dangers and uncertainties that will trigger our precise outcomes, efficiency, or achievements to be materially completely different from any future outcomes, efficiency or achievements expressed or implied by the forward-looking statements. These dangers and uncertainties are described extra absolutely within the Firm’s filings with the Securities and Alternate Fee, notably these elements recognized as “threat elements” in our annual report on Type 10-Okay filed March 11, 2021, and subsequent Quarterly Reviews on Type 10-Q. We’re offering this data as of the date of this press launch and don’t undertake any obligation to replace any forward-looking statements contained on this doc on account of new data, future occasions or in any other case, besides as required by regulation.
CONTACTS:
ReShape Lifesciences Investor Contact: Thomas Stankovich Chief Monetary Officer 949-276-6042 ir@ReShapeLifesci.com
Investor Contact: Daniel Kontoh-Boateng DKB Companions 862-213-1398 dboateng@dkbpartners.net
Copyright 2021 GlobeNewswire, Inc.
